EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
Gustave Roussy Cancer Campus
Villejuif, FranciaPublications in collaboration with researchers from Gustave Roussy Cancer Campus (3)
2023
2014
-
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 3, pp. 286-296
-
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, Vol. 32, Núm. 8, pp. 760-767